title: Association analysis of the PIP4K2A gene on chromosome 10p12 and schizophrenia in the Irish study of high density schizophrenia families (ISHDSF) and the Irish case-control study of schizophrenia (ICCSS).
abstract: Molecular studies support pharmacological evidence that phosphoinositide signaling is perturbed in schizophrenia and bipolar disorder. The phosphatidylinositol-4-phosphate-5-kinase type-II alpha (PIP4K2A) gene is located on chromosome 10p12. This region has been implicated in both diseases by linkage, and PIP4K2A directly by association. Given linkage evidence in the Irish Study of High Density Schizophrenia Families (ISHDSF) to a region including 10p12, we performed an association study between genetic variants at PIP4K2A and disease. No association was detected through single-marker or haplotype analysis of the whole sample. However, stratification into families positive and negative for the ISHDSF schizophrenia high-risk haplotype (HRH) in the DTNBP1 gene and re-analysis for linkage showed reduced amplitude of the 10p12 linkage peak in the DTNBP1 HRH positive families. Association analysis of the stratified sample showed a trend toward association of PIP4K2A SNPs rs1417374 and rs1409395 with schizophrenia in the DTNBP1 HRH positive families. Despite this apparent paradox, our data may therefore suggest involvement of PIP4K2A in schizophrenia in those families for whom genetic variation in DTNBP1 appears also to be a risk factor. This trend appears to arise from under-transmission of common alleles to female cases. Follow-up association analysis in a large Irish schizophrenia case-control sample (ICCSS) showed significant association with disease of a haplotype comprising these same SNPs rs1417374-rs1409395, again more so in affected females, and in cases with negative family history of the disease. This study supports a minor role for PIP4K2A in schizophrenia etiology in the Irish population.
authors.affiliation: Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia 23298-0424, USA. dlthiselton@vcu.edu
authors.forename: D L
authors.initials: DL
authors.lastname: Thiselton
authors.forename: B S
authors.initials: BS
authors.lastname: Maher
authors.forename: B T
authors.initials: BT
authors.lastname: Webb
authors.forename: T B
authors.initials: TB
authors.lastname: Bigdeli
authors.forename: F A
authors.initials: FA
authors.lastname: O'Neill
authors.forename: D
authors.initials: D
authors.lastname: Walsh
authors.forename: K S
authors.initials: KS
authors.lastname: Kendler
authors.forename: B P
authors.initials: BP
authors.lastname: Riley
mesh_terms: D016022:Case-Control Studies; D002879:Chromosomes, Human, Pair 10; D005260:Female; D008040:Genetic Linkage; D055106:Genome-Wide Association Study; D006239:Haplotypes; D006801:Humans; D007494:Ireland; D008297:Male; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012559:Schizophrenia / Q000235:genetics*
chemical_list: C514871:PIP4K2A protein, human; D017853:Phosphotransferases (Alcohol Group Acceptor)